Green AQbD-Guided Stability-Indicating RP-HPLC Method for Bempedoic Acid and Ezetimibe in Fixed-Dose Tablets
Abstract
A green, Analytical Quality by Design-guided, stability-indicating RP-HPLC method was developed for simultaneous estimation of bempedoic acid and ezetimibe in fixed-dose tablets. The 18:1 dose ratio and substantial differences in ionisation and lipophilicity were addressed using proportional standards and samples. Separation was achieved on a C18 column (150 × 4.6 mm, 5 µm) using 10 mM ammonium acetate at pH 4.8 and ethanol (42:58, v/v) at 1.0 mL/min. Bempedoic acid and ezetimibe eluted at approximately 4.32 and 6.47 min with resolution of 5.19. Linearity was established over 90–270 and 5–15 µg/mL, respectively. Mean tablet assays were 100.01% and 99.80%; recovery was 99.62–100.25%, and pooled intermediate-precision RSD values were below 0.4%. Forced degradation showed greater alkaline sensitivity of bempedoic acid and greater oxidative sensitivity of ezetimibe. All stressed peaks passed PDA purity assessment. Eco-Scale, AGREE, and normalised GAPI scores were 82, 0.78, and 0.74, respectively.